🔎 Trials Near Me

Beranda › Penyakit Paru Interstisial › Oklahoma

Uji klinis Penyakit Paru Interstisial di Oklahoma

5 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi di Oklahoma.

Kota di Oklahoma

Teks studi resmi (Bahasa Inggris)

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • University of Oklahoma, Oklahoma City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06911632

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • The University of Oklahoma Health Sciences Center, Oklahoma City
  • Oklahoma Heart Institute, Tulsa
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Oklahoma, Oklahoma City
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT01915511

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 12 Nov 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Oklahoma City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Mei 2025 · NCT05892614

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.